# Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

> **NCT01994681** · — · UNKNOWN · sponsor: **Rauscher, Gregory E., M.D. PA** · enrollment: 100 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01994681
- **Lead sponsor:** Rauscher, Gregory E., M.D. PA
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2014-10
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01994681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01994681, "Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01994681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*